Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
CRVO similar filings
- 31 Jan 25 CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference
- 10 Dec 24 CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies
- 3 Dec 24 Regulation FD Disclosure
- 27 Nov 24 CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
- 13 Nov 24 CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Filing view
External links